CATRIN-IMTM
CATRIN-IMTM, one of the three research divisions of the Czech Advanced Technology and Research Institute (CATRIN) at Palacký University Olomouc, focuses on basic and translational biomedical research with the aim to better understand the underlying cause of human infectious diseases and cancer, and to develop future human medicines, medical devices and diagnostics. Our vision is to facilitate private-public partnership and research collaboration, and to integrate member researchers into international platforms.
Research Groups
News
Our people
Josef Srovnal: The main goal is to benefit cancer patients
When as a fresh graduate from the First Faculty of Medicine, Charles University, Josef Srovnal...
Our people
I like the connection between research and practice
Years ago, Miloš Petřík entered the Faculty of Pharmacy at Charles University in Hradec Králové...
Papers
First study of its kind demonstrates activity of certain plant essential oils against the novel coronavirus
Essential oils of some plant species of the Lamiaceae family show notable antiviral activity against...
Featured publications
G. Gariglio, T. Hasenöhrl, K. Bendova, Z. Nový, C. Rangger, K. Kummer, B. D. Smith, B. Matuszczak, M. Petrik and C. Decristoforo
"Novel dimeric dual-modality FAP-targeted agents with favorable tumor retention for image-guided surgery: a preclinical study",
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol. 53, iss. 4, pp. 2578-2591, 2026.
IF = 7.6
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol. 53, iss. 4, pp. 2578-2591, 2026.
IF = 7.6
CATRIN-IMTM
DOI: 10.1007/s00259-025-07626-z
V. Das and M. Hajdúch
"Oncology drug repurposing as a blueprint for Alzheimer's therapy",
ALZHEIMER'S & DEMENTIA: TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, vol. 12, iss. 1, article no. e70231, 2026.
IF = 7.4
ALZHEIMER'S & DEMENTIA: TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, vol. 12, iss. 1, article no. e70231, 2026.
IF = 7.4
CATRIN-IMTM
DOI: 10.1002/trc2.70231
M. Kraihammer, H. P. Varbanov, K. Dvořáková Bendová, M. Petřík, A. Yap, G. Gariglio, H. Haas and C. Decristoforo
"Repurposing carboplatin-based Pt(IV)-deferoxamine conjugates for infection theranostics",
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 301, pp. 118216, 2026.
IF = 6.7
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 301, pp. 118216, 2026.
IF = 6.7
CATRIN-IMTM
DOI: 10.1016/j.ejmech.2025.118216
D. Baručić, J. Stanková, J. Kybic, M. Hajdúch and P. Džubák
"Group-based learning on label-free phase-contrast images across dose and exposure time improves bioactive compound classification",
MACHINE LEARNING WITH APPLICATIONS, vol. 24, pp. 100867, 2026.
IF = 6.1
MACHINE LEARNING WITH APPLICATIONS, vol. 24, pp. 100867, 2026.
IF = 6.1
CATRIN-IMTM
DOI: 10.1016/j.mlwa.2026.100867
N. K. Rampeesa, R. Gundla, S. Gurská, S. Yadam, S. Tangallapalli, S. R. Anugu, J. B. De Sanctis, P. Džubák, M. Hajdúch, N. K. Katari, V. Das and S. B. Jonnalagadda
"Optimization of Azaspirooxindolinone-based PROTACs targeting BTK: Synthesis, kinase profiling, and degradation analysis",
RESULTS IN CHEMISTRY, vol. 23, pp. 103145, 2026.
IF = 5.8
RESULTS IN CHEMISTRY, vol. 23, pp. 103145, 2026.
IF = 5.8
CATRIN-IMTM
DOI: 10.1016/j.rechem.2026.103145
V. Das, S. M. Modarres Mousavi, N. Annadurai, S. Sukur, F. Mehrnejad, S. Moradi, L. Malina, M. Kolaříková, V. Ranc, I. Frydrych, R. Kouřil, S. Hosseinkhani, M. Hajdúch and M. Nikkhah
"Hydrophobic residues in the α‐synuclein NAC domain drive seed‐competent fibril formation and are targeted by peptide inhibitors",
THE FEBS JOURNAL, vol. 293, iss. 1, pp. 134-155, 2026.
IF = 4.2
THE FEBS JOURNAL, vol. 293, iss. 1, pp. 134-155, 2026.
IF = 4.2
CATRIN-IMTM
DOI: 10.1111/febs.70222